These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 16181368

  • 1. Risk of hepatitis B exacerbation is low after transcatheter arterial chemoembolization therapy for patients with HBV-related hepatocellular carcinoma: report of a prospective study.
    Park JW, Park KW, Cho SH, Park HS, Lee WJ, Lee DH, Kim CM.
    Am J Gastroenterol; 2005 Oct; 100(10):2194-200. PubMed ID: 16181368
    [Abstract] [Full Text] [Related]

  • 2. Potential risk factors for the reactivation of the replication of hepatitis B and C viruses after transcatheter arterial chemoembolization of hepatocellular carcinoma.
    Lin CI, Lin ZY, Hsieh MY, Huang CF, Chen SH, Chuang WL.
    Kaohsiung J Med Sci; 2011 Dec; 27(12):554-9. PubMed ID: 22208538
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis B virus reactivation after three-dimensional conformal radiotherapy in patients with hepatitis B virus-related hepatocellular carcinoma.
    Kim JH, Park JW, Kim TH, Koh DW, Lee WJ, Kim CM.
    Int J Radiat Oncol Biol Phys; 2007 Nov 01; 69(3):813-9. PubMed ID: 17524569
    [Abstract] [Full Text] [Related]

  • 4. Effects of antiviral therapy on hepatitis B virus reactivation and liver function after resection or chemoembolization for hepatocellular carcinoma.
    Lao XM, Luo G, Ye LT, Luo C, Shi M, Wang D, Guo R, Chen M, Li S, Lin X, Yuan Y.
    Liver Int; 2013 Apr 01; 33(4):595-604. PubMed ID: 23402625
    [Abstract] [Full Text] [Related]

  • 5. Hepatitis B virus reactivation in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization therapy.
    Peng JW, Lin GN, Xiao JJ, Jiang XM.
    Asia Pac J Clin Oncol; 2012 Dec 01; 8(4):356-61. PubMed ID: 22897940
    [Abstract] [Full Text] [Related]

  • 6. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
    Li M, Lu C, Cheng J, Zhang J, Cao C, Xu J, Xu J, Pan H, Zhong B, Tucker S, Wang D.
    J Gastroenterol Hepatol; 2009 Aug 01; 24(8):1437-44. PubMed ID: 19486255
    [Abstract] [Full Text] [Related]

  • 7. Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma.
    Jang JW, Choi JY, Bae SH, Kim CW, Yoon SK, Cho SH, Yang JM, Ahn BM, Lee CD, Lee YS, Chung KW, Sun HS.
    J Hepatol; 2004 Sep 01; 41(3):427-35. PubMed ID: 15336446
    [Abstract] [Full Text] [Related]

  • 8. A randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization.
    Jang JW, Choi JY, Bae SH, Yoon SK, Chang UI, Kim CW, Cho SH, Han JY, Lee YS.
    Hepatology; 2006 Feb 01; 43(2):233-40. PubMed ID: 16440357
    [Abstract] [Full Text] [Related]

  • 9. [Cytokine-induced killer cell fusion to lower recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization sequentially combined with radiofrequency ablation: a randomized trial].
    Zhao M, Wu PH, Zeng YX, Xia JC, Zhang FJ, Xian LJ, Zhang YP, Zhou K, Fan WJ, Zhang L, Gao F, Zhou QM.
    Zhonghua Yi Xue Za Zhi; 2006 Jul 11; 86(26):1823-8. PubMed ID: 17054858
    [Abstract] [Full Text] [Related]

  • 10. Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinoma.
    Huang L, Li J, Lau WY, Yan J, Zhou F, Liu C, Zhang X, Shen J, Wu M, Yan Y.
    J Gastroenterol Hepatol; 2012 Jan 11; 27(1):158-64. PubMed ID: 21871026
    [Abstract] [Full Text] [Related]

  • 11. Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels.
    Huang G, Lai EC, Lau WY, Zhou WP, Shen F, Pan ZY, Fu SY, Wu MC.
    Ann Surg; 2013 Mar 11; 257(3):490-505. PubMed ID: 22868358
    [Abstract] [Full Text] [Related]

  • 12. Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study.
    Dan JQ, Zhang YJ, Huang JT, Chen MS, Gao HJ, Peng ZW, Xu L, Lau WY.
    Eur J Surg Oncol; 2013 Aug 11; 39(8):865-72. PubMed ID: 23597497
    [Abstract] [Full Text] [Related]

  • 13. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
    Jin YJ, Shim JH, Lee HC, Yoo DJ, Kim KM, Lim YS, Suh DJ.
    J Gastroenterol Hepatol; 2011 Sep 11; 26(9):1380-8. PubMed ID: 21884247
    [Abstract] [Full Text] [Related]

  • 14. [Effect of transcatheter arterial chemoembolization on HBV DNA level in primary liver cancer patients].
    Xu J, Wang YH, Xia JL, Ge NL, Chen Y, Ye SL.
    Ai Zheng; 2009 May 11; 28(5):520-3. PubMed ID: 19624882
    [Abstract] [Full Text] [Related]

  • 15. Changes of HBV DNA After Chemoembolization for Hepatocellular Carcinoma and the Efficacy of Antiviral Treatment.
    Lin XJ, Lao XM, Shi M, Li SP.
    Dig Dis Sci; 2016 Sep 11; 61(9):2465-76. PubMed ID: 27105647
    [Abstract] [Full Text] [Related]

  • 16. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.
    Yin J, Zhang H, Li C, Gao C, He Y, Zhai Y, Zhang P, Xu L, Tan X, Chen J, Cheng S, Schaefer S, Cao G.
    Carcinogenesis; 2008 Sep 11; 29(9):1685-91. PubMed ID: 18192693
    [Abstract] [Full Text] [Related]

  • 17. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.
    Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, Liu CJ, Shih WL, Kao JH, Chen DS, Chen CJ.
    J Natl Cancer Inst; 2005 Feb 16; 97(4):265-72. PubMed ID: 15713961
    [Abstract] [Full Text] [Related]

  • 18. The impact of hepatitis B viral load on recurrence after complete necrosis in patients with hepatocellular carcinoma who receive transarterial chemolipiodolization: implications for viral suppression to reduce the risk of cancer recurrence.
    Jang JW, Choi JY, Bae SH, Yoon SK, Woo HY, Chang UI, Kim CW, Nam SW, Cho SH, Yang JM, Lee CD.
    Cancer; 2007 Oct 15; 110(8):1760-7. PubMed ID: 17724708
    [Abstract] [Full Text] [Related]

  • 19. [Therapeutic effect and prognosis of interferon therapy after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma associated with hepatitis B virus].
    Gao J, Li XS, Shen W, Wu XC, Feng XX, Ren H.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug 15; 12(8):460-2. PubMed ID: 15329203
    [Abstract] [Full Text] [Related]

  • 20. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
    Park KW, Park JW, Choi JI, Kim TH, Kim SH, Park HS, Lee WJ, Park SJ, Hong EK, Kim CM.
    J Gastroenterol Hepatol; 2008 Mar 15; 23(3):467-73. PubMed ID: 17764529
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.